BUSINESS OVERVIEW

BioGenex is at the forefront of the emerging discipline of molecular pathology, the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. The company designs, develops and commercializes systems for Tumor diagnosis, prognosis, precision medicine and life science research. BioGenex’s industry-leading next-generation cytogenetic FISH workflow solution and miRNA system for characterization of Cancer of Unknown Primary (CUP) and undifferentiated tumors are revolutionizing pathology. Proprietary fully-automated molecular pathology workstations from BioGenex are the most advanced systems available globally.

Explore

Mission

To become a global molecular medicine company providing affordable solutions for life science research and personalized medicine

Our Core Values

At BioGenex, our performance-oriented culture and customer-centric approach are the foundation of our success. Built upon that foundation, we have erected six pillars of business – they define who we are and guide every decision we make.

News

Anti-Microglia

IHC on Tonsil Tissue

Click Here

Anti-ATRX

IHC on Breast Carcinoma Tissue

Click Here

Testimonials

My experience with EZ-Retrievel is great, a comfortable and safe system when performed antigenic recovery for conventional IHC and multiple-IHC. I never had a problem with my tissues and the quality of the results were very reproducible. Thanks!!!